Abstract:Objective To explore the relationship between the extent of coronary artery lesions and plasma brain natriurefic peptide(BNP)levels in the patients with coronary artery disease(CAD)except for congestive heart failure(CHF).Method Seventy CAD patients without CHF evidenced by dinical manifestation and coronary arte- riography(CAG)from Cardiology Depamnent of the First Affiliated Hospital of Zhejiang University School of Medicine,China,were enrolled in the study.These patients were diagnozed under coronary arteriography(CAG) during March to May of 2007.They were divided into 3 groups:stable angina goup(24 patients),unstable angina group(25 patients),myocardial infarction group(21 patients).Twenty patients without coronary history and with normal CAG served as controls.Plasma BNP concentrations were measured with ELASA before CAG.The coronary lesion vessels and scores were estimated after CAG.The relationship between BNP levels and the coronary lesion vessels,as well as scores in CAD was analyzed.The data were expressed as(x±s)and was analyzed by using 2 independent samples test and spearman correlation with SPSS 13.0.A P value less than 0.01 indicated statistical significance.Results The plasma BNP concentrations in the patients,especially in the patients with myocardial infarction,were significantly higher than those in the controls.Spearman analysis showed that there was a positive correlation between the BNP levels and coronary lesion vessels(r1=0.309,P=0.01),also between BNP and coronary lesion score(r2=0.279,P=0.01).Conclusions In the patients without congestive heart failure,the more serious the coronary artery lesions,the higher the plasma BNP concentrations were.The degree of myocardial ischemia caused by coronary artery lesions was correlated with the plasma BNP level.Plasma BNP concentration could be valuable for the extent of coronary artery lesions in the patients of coronary artery disease.

Brain Natriuretic Peptide and Heart Valve Disease

Plasma Concentration of Brain Natriuretic Peptide and Heart Dysfunction

Brain Natriuretic Peptide and Optimal Management of Heart Failure.

Advances in Research of Brain Natriuretic Peptide in Cardiovascular Disease

Brain Natriuretic Peptide and Current Clinical Applications

Clinical Significance and Progress in Research of Perioperative Brain Natriuretic Peptide

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Brain Natriuretic Peptide and Sepsis-Induced Myocardial Dysfunction

Correlativity Between Plasma Brain Natriuretic Peptide Level and Cardial Metrical Indices in Hypertensive Patients

Clinical evaluation effect of brain natriuretic peptide in patients with heart failure

Clinical Significance of N-terminal Pro-Brain Natriuretic Peptide

Recent Advances in Natriuretic Peptide Family Genes and Cardiovas-Cular Diseases

Brain Natriuretic Peptide: A Potential Indicator of Cardiomyogenesis after Autologous Mesenchymal Stem Cell Transplantation?

Clinical Application of Natriuretic Peptide

Levels of Brain Natriuretic Peptide Are Associated with Peripheral Arterial Disease in Subjects with Type-2 Diabetes Mellitus

Relevance of Brain Natriureticpeptide Level and Cardiac Function in Heart Failure Patients

Significance of Brain Natriuretic Peptide in Early Risk Stratification and Prognosis of Acute Coronary Syndromes

Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review

Brain natriuretic peptide is a novel cardiac hormone

Issues that challenge our attention about B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in clinical use

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index